Microreviews, Review
Saccharomyces cerevisiae in cancer research: modeling tumor biology and enabling drug discovery
Graziana Assalve1,a, Paola Lunetti1,a, Annalisa Fai1, Luca Frattaruolo2, Anna Rita Cappello2, Alessandra Ferramosca1,* and Vincenzo Zara1
By combining genetic tractability with conservation of key cellular pathways, Saccharomyces cerevisiae is emerging as a versatile model for cancer biology and a scalable platform for identifying therapeutic targets and vulnerabilities.
Prohibitins: emerging host targets of bacteria and viruses at the plasma membrane, mitochondria, and cytoplasm
Grecia O. Rivera-Palomino1,2 and Arianne L. Theiss1,2,3
Prohibitins are emerging as central host hubs exploited by bacteria and viruses to rewire signaling and mitochondrial dynamics. The current review discusses Prohibitins in host-pathogen interplay and their potential as novel anti-infective targets.
Outer membrane vesicles in Vibrio species: Roles in biofilm formation and pathogenesis
Kumari Shambhavi and Durg Vijai Singh
This review explores current knowledge on outer membrane vesicles (OMVs) in Vibrio species, highlighting their roles in pathogenesis, host interaction, and marine ecology; and identifies major knowledge gaps, outlining key methodological challenges and future prospects for OMV-based applications.
The mechanism of Tat-dependent protein translocation
Thomas Brüser1,* and Carsten Sanders2,3,4
This review integrates mechanistically relevant biochemical, molecular, and structural studies on Tat-dependent translocation of folded proteins into an in its molecular detail new comprehensive explanation of how the Tat system mediates protein transport.
From the gut to the lungs: The role of gut microbiota in chronic obstructive pulmonary disease and related research progress
Simin Yang1,2, Shuting Zeng1,2, Yongan Deng1,2, Xiaodong Duan1,2, Chengkai Chen1,2, Luyun Sun2, Yongkang Qiao2 and Zunpeng Shu1,2
This article provides new ideas and directions for the basic research and clinical practice of COPD by comprehensively sorting out the association between gut microbiota and COPD.
Protein arginine methyltransferases in protozoan parasites: a new path for antiparasitic chemotherapy?
Gustavo D. Campagnaro1,* and Sébastien Pomel2
This review discusses the activity and the relevance of arginine methyltransferases for the survival of pathogenic kinetoplastids, apicomplexans and amoebas, and how these enzymes could be exploited as drug targets.
Gut microbiota and ankylosing spondylitis: current insights and future challenges
Andrei Lobiuc1, Liliana Groppa2, Lia Chislari2, Eugeniu Russu2,3, Marinela Homitchi2,3, Camelia Ciorescu2,3, Sevag Hamamah4, I. Codruta Bran1 and Mihai Covasa1
This review explores the growing role of gut microbiota in AS and its potential to reshape targeted treatment strategies and facilitate development of adjunct therapies to address disease onset and progression.
Advancements in vaginal microbiota, Trichomonas vaginalis, and vaginal cell interactions: Insights from co-culture assays
Fernanda Gomes Cardoso and Tiana Tasca
This review updates co-culture and co-incubation techniques for studying interactions of Lactobacillus spp., representing a pre-dominant member of the healthy vaginal microbiota; Candida spp., the most abundant yeast in the vagina, and T. vaginalis, responsible for the most widespread nonviral STI worldwide.
Influence of cervicovaginal microbiota on Chlamydia trachomatis infection dynamics
Emily Hand1, Indriati Hood-Pishchany1,2, Toni Darville1,2 and Catherine M. O’Connell2
This review examines the complex interplay between the cervicovaginal microbiome, C. trachomatis infection, and host immune responses, highlighting the role of metabolites such as short-chain and long-chain fatty acids, indole, and iron in modulating pathogen survival and host defenses.
Antibiotic use in childhood alters the gut microbiota and predisposes to overweight
June 20, 2016
This article comments on work published by Korpela et al. (Nat Commun, 2016), which investigates the correlation between the use of antibiotics in early life and the excessive weight gain in later childhood.
Bacterial outer membrane vesicle biogenesis: a new mechanism and its implications
May 10, 2016
This article comments on work published by Roier et al. (Nat Commun, 2016), which proposes a novel and highly conserved bacterial outer membane vesicle biogenesis mechanism based on phospholipid accumulation in the outer leaflet of the outer membrane.
A plant Bcl-2-associated athanogene is proteolytically activated to confer fungal resistance
April 16, 2016
This article comments on work published by Li et al. (Plant Cell, 2016), which focuses on the role of Bcl-2-associated athanogene 6 (BAG6) in plant innate immunity, showing that BAG6 plays a key role in basal plant defense against fungal pathogens.
Chemical proteomics approach reveals the direct targets and the heme-dependent activation mechanism of artemisinin in Plasmodium falciparum using an activity-based artemisinin probe
April 5, 2016
This article comments on work published by Wang et al. (Nat Commun, 2014), which provides insights into the mode-of-action of artemisinin and its specificity against malaria parasites.
Translational repression in malaria sporozoites
April 5, 2016
This article comments on work published by Zhang et al. (PLoS Pathog, 2016), which summarizea recent advances in the translational repression of gene expression in the malaria sporozoite.
When and where? Pathogenic Escherichia coli differentially sense host D-serine using a universal transporter system to monitor their environment
March 31, 2016
This article comments on work published by Connolly et al. (PLoS Pathog, 2016), which describes the discovery of a functional and previously uncharacterized D-serine uptake system in E. coli.
The bacterial cell cycle checkpoint protein Obg and its role in programmed cell death
March 16, 2016
This article comments on work published by Dewachter et al. (mBio, 2015), which identified a programmed cell death mechanism in Escherichia coli that is triggered by a mutant isoform of the essential GTPase ObgE.
Control of the gut microbiome by fecal microRNA
March 9, 2016
This article comments on work published by Liu et al. (Cell Host & Microbe, 2016), which identifies miRNAs in gut lumen and feces of both mice and humans that were able to enter bacteria, specifically regulate bacterial gene transcripts and affect bacterial growth thereby regulating the gut microbiome.